Document:

AGREEMENT

     THIS AGREEMENT, made as of the 1st day of June, 2001 by and between Derma
Sciences, Inc., a business corporation organized under the laws of the
Commonwealth of Pennsylvania ("Employer"), and Edward J. Quilty ("Employee").

     WHEREAS, Employee is currently employed by Employer as its President,
Chairman and Chief Executive Officer, and

     WHEREAS, the parties desire to memorialize the terms and conditions of
Employee's employment by Employer,

     NOW, THEREFORE, the parties hereto, in consideration of the mutual promises
and covenants herein contained, hereby agree as follows:

     1. EMPLOYMENT. Employer hereby employs Employee, and Employee agrees to be
employed by Employer, as Employer's President, Chairman and Chief Executive
Officer upon the terms and conditions hereinbelow set forth.

     2. TIME AND EFFORTS. Employee will devote substantially all of his business
time and efforts to his duties hereunder.

     3. COMPENSATION. During the Term hereof Employer shall pay compensation to
Employee as follows:

          (a) Base compensation at the rate of Two Hundred Thousand Dollars
     ($200,000) per year;

          (b) Bonus, stock options and/or such other incentive compensation as
     may be determined by Employer's board of directors upon recommendation of
     its compensation committee.

                                       1

<PAGE>

     Reviews by the compensation committee of Employee's base compensation and
incentive compensation shall be undertaken not less often than annually. The
principal criteria utilized by the compensation committee in the conduct of its
reviews shall be the extent to which Employer attains its performance objectives
and the extent of Employee's contributions thereto.

     4. TERM. This Agreement shall be effective as of June 1, 2001 and shall
expire on May 31, 2002 unless renewed or extended by mutual agreement of the
parties hereto.

     5. SEVERANCE. Upon the failure by Employer, on or prior to each anniversary
hereof, to extend to Employee its offer to renew this Agreement for the
succeeding twelve month period, and provided only that Employer's failure to
renew this Agreement is "without cause," Employer shall pay to Employee
severance compensation in the amount of one year's base compensation at the rate
most recently in effect pursuant to paragraph 3(a) hereof.

     6. CHANGE IN CONTROL. Within six months of the occurrence of a "change in
control" of Employer (defined below), Employee may, but shall have no obligation
to, tender his resignation from Employer and receive severance compensation as
provided in paragraph 5 above to the same extent as if Employer failed to renew
this Agreement "without cause." For purposes of this paragraph, a "change in
control" shall mean a change in ownership of stock possessing greater than fifty
percent (50%) of the total combined voting power of all classes of stock
entitled to vote of Employer.

     7. OPTION EXERCISE EXTENSION. In the event either that Employer fails to
renew this Agreement "without cause" or Employee tenders his resignation upon a
"change in control," then the period to exercise any option to purchase the
securities of Employer of

                                       2

which Employee may be possessed shall be extended to the expiration thereof as
set forth in the option instrument.

     IN WITNESS WHEREOF, this Agreement has been executed by Employee and
Employer by a member of its board of directors and its compensation committee
thereunto duly authorized.

                                 EMPLOYER:

                                 DERMA SCIENCES, INC.

                                 By:
                                    -------------------------------------------
                                       Stephen T. Wills, CPA, MST
                                       Chairman - Compensation Committee

                                 EMPLOYEE:

                                 ----------------------------------------------
                                 Edward J. Quilty

                                       3AGREEMENT

     THIS AGREEMENT, made as of the 1st day of June, 2001 by and between Derma
Sciences, Inc., a business corporation organized under the laws of the
Commonwealth of Pennsylvania ("Employer"), and John E. Yetter, CPA ("Employee").

     WHEREAS, Employee is currently employed by Employer as its Vice President
and Chief Financial Officer, and

     WHEREAS, the parties desire to memorialize the terms and conditions of
Employee's employment by Employer,

     NOW, THEREFORE, the parties hereto, in consideration of the mutual promises
and covenants herein contained, hereby agree as follows:

     1. EMPLOYMENT. Employer hereby employs Employee, and Employee agrees to be
employed by Employer, as Employer's Vice President and Chief Financial Officer
upon the terms and conditions hereinbelow set forth.

     2. TIME AND EFFORTS. Employee will devote substantially all of his business
time and efforts to his duties hereunder.

     3. COMPENSATION. During the Term hereof Employer shall pay compensation to
Employee as follows:

          (a) Base compensation at the rate of One Hundred Sixty Thousand Five
     Hundred Dollars ($160,500) per year;

          (b) Bonus, stock options and/or such other incentive compensation as
     may be determined by Employer's board of directors upon recommendation of
     its compensation committee.

                                       1

<PAGE>

     Reviews by the compensation committee of Employee's base compensation and
incentive compensation shall be undertaken not less often than annually. The
principal criteria utilized by the compensation committee in the conduct of its
reviews shall be the extent to which Employer attains its performance objectives
and the extent of Employee's contributions thereto.

     4. TERM. This Agreement shall be effective as of June 1, 2001 and shall
expire on May 31, 2002 unless renewed or extended by mutual agreement of the
parties hereto.

     5. SEVERANCE. Upon the failure by Employer, on or prior to each anniversary
hereof, to extend to Employee its offer to renew this Agreement for the
succeeding twelve month period, and provided only that Employer's failure to
renew this Agreement is "without cause," Employer shall pay to Employee
severance compensation in the amount of one year's base compensation at the rate
most recently in effect pursuant to paragraph 3(a) hereof.

     6. CHANGE IN CONTROL. Within six months of the occurrence of a "change in
control" of Employer (defined below), Employee may, but shall have no obligation
to, tender his resignation from Employer and receive severance compensation as
provided in paragraph 5 above to the same extent as if Employer failed to renew
this Agreement "without cause." For purposes of this paragraph, a "change in
control" shall mean a change in ownership of stock possessing greater than fifty
percent (50%) of the total combined voting power of all classes of stock
entitled to vote of Employer.

     7. OPTION EXERCISE EXTENSION. In the event either that Employer fails to
renew this Agreement "without cause" or Employee tenders his resignation upon a
"change in control," then the period to exercise any option to purchase the
securities of Employer of

                                       2

<PAGE>

which Employee may be possessed shall be extended to the expiration thereof as
set forth in the option instrument.

     IN WITNESS WHEREOF, this Agreement has been executed by Employee and
Employer by a member of its board of directors and its compensation committee
thereunto duly authorized.

                                    EMPLOYER:

                                     DERMA SCIENCES, INC.

                                     By:
                                        ----------------------------------------
                                           Edward J. Quilty
                                           President and Chief Executive Officer

                                    EMPLOYEE:

                                    --------------------------------------------
                                           John E. Yetter, CPA

                                       3Exhibit 10.2

                       AMENDMENT NO. 1 TO LETTER OF INTENT

         This   Amendment  No.  1  to  that  certain   Letter  of  Intent  (this
"Amendment"),  dated as of June 13, 2001, by and between Gold Standard,  Inc., a
Utah corporation ("Gold  Standard"),  and Vector Medical  Technologies,  Inc., a
Delaware corporation ("Vector").

                               W I T N E S E T H :
                                - - - - - - - - -

         WHEREAS, Gold Standard and Vector are parties to that certain Letter of
Intent dated as of April 16, 2001 (the "Existing Agreement"); and

         WHEREAS,  Gold  Standard  and  Vector  desire  to  amend  the  Existing
Agreement to effect the changes provided for herein.

         NOW,  THEREFORE,  in consideration of the premises and mutual covenants
contained herein,  the receipt and sufficiency of which is hereby  acknowledged,
the parties hereto agree as follows:

         1.  Effective as of the date hereof,  the Existing  Agreement is hereby
amended by  deleting  Paragraph  5 in its  entirety  and  replacing  it with the
following paragraph:

              5. The parties  agree to exercise  their best efforts  between now
              and June 30, 2001,  to negotiate  and execute a definitive  merger
              agreement.

         2. Paragraphs 8,9,10 and 11 of this Agreement shall be deleted in their
entirety and the following paragraph shall be inserted in lieu thereof:

              8.  The  parties  and  their  respective  employees,   affiliates,
              shareholders   and  controlling   persons   acknowledge  that  all
              information,  documents,  customer lists,  suppliers,  trademarks,
              materials, specifications,  business strategies or any other ideas
              relating to the business of the other party (referred to herein as
              "Confidential  Information") whether prepared or generated by them
              or any other  party  coming  into their  possession  or  knowledge
              during the Option Period shall remain the exclusive,  confidential
              property  of the  other  party,  except  to the  extent  expressly
              authorized in writing by such party for dissemination. The parties

<PAGE>

              further   acknowledge   and  agree  that  all  such   Confidential
              Information  constitutes  trade  secrets.  From  the  date of this
              Agreement through and including the second anniversary hereof (the
              "Restricted  Period"),  the parties shall not disclose any of such
              Confidential  Information  to any third  party  without  the prior
              written  consent of the other party and shall take all  reasonable
              steps and actions  necessary  to maintain the  confidentiality  of
              such Confidential Information.

              9. It is expressly understood that this Agreement is a non-binding
              letter of intent and that no obligation  of any nature  whatsoever
              is intended to be created, except as set forth in Paragraph 5, 8 &
              9 hereof.  Subject  to  satisfactory  progress  being  made in the
              parties' due  diligence  review,  the parties  shall  concurrently
              proceed  to  negotiate  a  definitive   agreement   governing  the
              acquisition.  The  obligations  of the parties to  consummate  the
              transaction  contemplated  hereby shall be subject in all respects
              to the  negotiation,  execution  and  delivery  of the  definitive
              agreement  and  the  satisfaction  of  the  conditions   contained
              therein,  and neither  party shall have any liability to the other
              if the  parties  fail for any  reason to  execute  the  definitive
              agreement.  Each  party  shall be  responsible  for the  costs and
              expenses  incurred  by it in  connection  with this letter and the
              transactions  contemplated  hereby.  This  letter may be signed in
              counterparts.

         3. This Amendment shall be governed by and construed in accordance with
the laws of the State of Florida,  without  regard to principles of conflicts of
law.

         4. Except as otherwise  specifically set forth herein, all of the terms
and provisions of the Existing Agreement shall remain in full force and effect.

         IN WITNESS WHEREOF,  the undersigned have executed this Amendment as of
the day first above written.

                                    GOLD STANDARD, INC.

                                    By:  /s/ Scott L. Smith
                                    --------------------------------------------
                                    Name:    Scott L. Smith
                                    Title: President and Chief Financial Officer

                                    VECTOR MEDICAL TECHNOLOGIES, INC.

                                    By:  /s/ David Fater
                                    --------------------------------------------
                                    Name:  David Fater
                                    Title:  Chief Financial Officer

                                        2

<PAGE>

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00026-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00026-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00026-of-00352.parquet"}]]